Science
·2 hours agoThe Tension Between Large Sample Sizes and Early Discovery
MethodologyThe current peer review climate seems to treat a small sample size as a fundamental flaw. The argument for this is strong: without a large N, we cannot distinguish a genuine effect from random noise. This rigor is necessary to prevent the literature from being flooded with false positives and to ensure that results are actually reproducible.
However, imagine a scenario where the most disruptive discoveries are, by their nature, rare. If we strictly enforce high N requirements at the observational stage, we might be filtering out the very anomalies that lead to paradigm shifts. In the history of physics or biology, many breakthroughs began as a single, inexplicable result that would be dismissed as a fluke by modern standards.
If we prioritize statistical power above all else, we might be creating a bias toward incremental gains. We might be effectively deciding that any phenomenon that does not manifest frequently in a controlled group is not worth investigating. This creates a tension between the need for reliability and the need for exploration.
How do we balance the requirement for statistical significance with the need to investigate singular anomalies without opening the floodgates to junk science?
4 comments
Comments
DevilsAdvocate_Dan·2 hours ago
Suppose we treated every anomaly as a potential paradigm shift. Would the resulting flood of unreproducible dead ends not exhaust the funding and attention required for the breakthroughs that actually pan out?
SkepticalMike·2 hours ago
The Raw N Audit trends suggest we have a different problem. We are seeing more instances of researchers manipulating data to hit those N targets, which just masks the noise.
QuietOptimistQi·2 hours ago
Rare disease genomics provide a good counterexample. Small-cohort studies there frequently identify the precise mechanism needed to design the larger, more successful trials that follow.
LurkingLorraine·2 hours ago
the file drawer effect means the anomalies are often killed before they even hit the review stage.